The 130th Annual Meeting of APHA

Abstract #43860

Dawne M. Harris, BA, Jane E. Miller, PhD, and Diane M. Davis, BA. Institute for Health, Health Care Policy and Aging Research, Rutgers University, 30 College Avenue, New Brunswick, NJ 08901-1293, 732-932-3105 ext.242, dharris@ihhcpar.rutgers.edu

BACKGROUND. Breast cancer is the second leading cause of cancer death among women. While the incidence of breast cancer is 13% higher in non-Hispanic White women, mortality in non-Hispanic Black women is 28% higher. Engaging in regular screening is a proactive way for all women to reduce their breast cancer risk.

OBJECTIVE. To analyze factors that limit compliance with breast self-examination (BSE), clinical breast exam (CBE), and mammograms, using a nationally representative sample.

METHODS. Data were from the 1992 National Health Interview Survey Cancer Control Supplement. The core sample consisted of 4,589 non-Hispanic White and non-Hispanic Black women. Logistic regression was used to estimate the relative odds of knowledge of BSE and mammograms, and compliance with BSE, CBE, and mammograms.

RESULTS. Although non-Hispanic White and non-Hispanic Black women were equally likely to know BSE and have heard of mammograms, when the analysis was restricted to those who knew of the pertinent test, non-Hispanic Black women were 1.73 times as likely to be BSE compliant and 1.35 times as likely to be mammogram compliant. Non-Hispanic Black women were almost twice as likely to be CBE compliant. Having higher breast cancer knowledge, more education, and a usual source of care significantly increased the likelihood of being CBE and mammogram compliant, but did not affect BSE compliance.

IMPLICATIONS. Programs should be designed to raise awareness of screening tests and to address barriers that hinder women from receiving clinical screening exams. A consistent set of screening guidelines would also reduce confusion.

Learning Objectives:

• By the conclusion of the session, participants will be able....
• • To identify the factors associated with breast cancer screening knowledge and compliance.
  • To distinguish between the different predictors of clinican-dependent screens versus non-clinical tests.
  • To understand how screening knowledge translates into compliance with each screening test.

Keywords: Breast Cancer Screening, Minority Health

Presenting author's disclosure statement:
I do not have any significant financial interest/arrangement or affiliation with any organization/institution whose products or services are being discussed in this session.